A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Clinical trial NCT06618287 · RECRUITING

Trial details

NCT number: NCT06618287
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer Breast Cancer

Start date: 2025-02-04
Primary completion: 2031-02-26
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.